Cell Reports (May 2021)

Sarcomere function activates a p53-dependent DNA damage response that promotes polyploidization and limits in vivo cell engraftment

  • Anthony M. Pettinato,
  • Dasom Yoo,
  • Jennifer VanOudenhove,
  • Yu-Sheng Chen,
  • Rachel Cohn,
  • Feria A. Ladha,
  • Xiulan Yang,
  • Ketan Thakar,
  • Robert Romano,
  • Nicolas Legere,
  • Emily Meredith,
  • Paul Robson,
  • Michael Regnier,
  • Justin L. Cotney,
  • Charles E. Murry,
  • J. Travis Hinson

Journal volume & issue
Vol. 35, no. 5
p. 109088

Abstract

Read online

Summary: Human cardiac regeneration is limited by low cardiomyocyte replicative rates and progressive polyploidization by unclear mechanisms. To study this process, we engineer a human cardiomyocyte model to track replication and polyploidization using fluorescently tagged cyclin B1 and cardiac troponin T. Using time-lapse imaging, in vitro cardiomyocyte replication patterns recapitulate the progressive mononuclear polyploidization and replicative arrest observed in vivo. Single-cell transcriptomics and chromatin state analyses reveal that polyploidization is preceded by sarcomere assembly, enhanced oxidative metabolism, a DNA damage response, and p53 activation. CRISPR knockout screening reveals p53 as a driver of cell-cycle arrest and polyploidization. Inhibiting sarcomere function, or scavenging ROS, inhibits cell-cycle arrest and polyploidization. Finally, we show that cardiomyocyte engraftment in infarcted rat hearts is enhanced 4-fold by the increased proliferation of troponin-knockout cardiomyocytes. Thus, the sarcomere inhibits cell division through a DNA damage response that can be targeted to improve cardiomyocyte replacement strategies.

Keywords